Membrane association of the short transglutaminase type 2 splice variant (TG2-S) modulates cisplatin resistance in a human hepatocellular carcinoma (HepG2) cell line

Meshram, D.D. orcid.org/0000-0002-7390-2609, Fanutti, C., Pike, C.V.S. et al. (1 more author) (2024) Membrane association of the short transglutaminase type 2 splice variant (TG2-S) modulates cisplatin resistance in a human hepatocellular carcinoma (HepG2) cell line. Current Issues in Molecular Biology, 46 (5). pp. 4251-4270. ISSN 1466-531X

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Keywords: hepatocellular carcinoma (HCC); HepG2; transglutaminase 2 (TG2); cisplatin; chemoresistance; sub-cellular localisation; apoptosis; autophagy
Dates:
  • Published: May 2024
  • Published (online): 2 May 2024
  • Accepted: 29 April 2024
  • Submitted: 23 March 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > School of Biosciences (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Jun 2024 15:04
Last Modified: 03 Jun 2024 15:04
Status: Published
Publisher: MDPI AG
Refereed: Yes
Identification Number: 10.3390/cimb46050259
Open Archives Initiative ID (OAI ID):

Export

Statistics